Tarsons Products profit drops 52% as finance and depreciation costs bite
Revenue crept higher while bottom-line profitability collapsed. The company also disclosed an unauthorised ₹4.1 cr payout to its top directors.
— 2 earlier stories on Tarsons Products Ltd. →What's new
- Consolidated net profit fell to ₹14.3 cr from ₹29.8 cr last year.
- Finance costs reached ₹22.5 cr and depreciation hit ₹96.5 cr.
- Management paid itself ₹4.1 cr in excess remuneration requiring a shareholder waiver.
Why it matters
The gap between top-line growth and bottom-line erosion is stark. The excess remuneration disclosure suggests poor internal controls on executive pay at a time when shareholders are already seeing profit margins sliced in half.
What we're watching
- Whether shareholders approve the waiver for the excess executive pay.
- If the high depreciation cost trajectory from the new facilities moderates in FY27.
- The recovery timeline for margins.
The full read
Tarsons Products ended FY26 with a painful disconnect between sales and earnings. While revenue managed a modest 7.7% lift to ₹422.5 crore on the back of domestic demand, the profit line collapsed. Consolidated net profit fell 52% to ₹14.3 crore, dragged down by heavy non-operating charges. Finance costs grew to ₹22.5 crore, and depreciation climbed to ₹96.5 crore, reflecting the burden of recent capital investments. The company further complicated its narrative by disclosing ₹4.1 crore in excess remuneration paid to its managing director and whole-time director. Tarsons must now solicit a shareholder waiver for these payments. Investors are left with a company that is growing its footprint but struggling to convert that scale into cash, all while needing to clean up a governance oversight regarding executive compensation.